| Name | Title | Contact Details |
|---|
Appli-Tec Inc is a Salem, NH-based company in the Business Services sector.
Peterson Sullivan LLP, founded in Seattle over 60 years ago, provides comprehensive accounting, audit, and tax services to publicly traded companies, closely held businesses, nonprofits, and high net worth individuals throughout the Pacific Northwest and internationally. Our close to 200 professionals draw on a deep pool of knowledge, skill and experience to provide sound advice and serve our client`s needs. We are committed to technical excellence, uncommonly good communication, and exemplary client service.
Guardian, The is a Charlottetown, PE-based company in the Business Services sector.
The United States Agency for Global Medias mission is to inform, engage and connect people around the world in support of freedom and democracy.
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)